* Treatment usually involves medications or surgery, but both come with risks and potential side effects, leading to a search for alternative options.
* A case study presents a 58-year-old male with refractory trigeminal neuralgia of the ophthalmic branch that was successfully treated with onabotulinum toxin type A, suggesting it could be a viable option before considering surgery.